Remove 2018 Remove Medical Remove Patients Remove Utilities
article thumbnail

Utilization of Treatment for Chlamydia and Gonorrhea in the Primary Care Setting Using the American Family Cohort [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Study Design and Analysis: A retrospective cohort from 2018-2022. Setting or Dataset: Electronic health records from the PRIME Registry, years 2018-2022. Intervention/Instrument: Key patient characteristics such as race/ethnicity and social determinants of health were considered. treatment rates, respectively.

article thumbnail

How Mental Health & SUD Bias Impact ED Physical Care

Physician's Weekly

Mental health and SUD bias impact the quality of ED care that patients with these conditions receive for physical health concerns, according to research. What the Patients Said According to the study, three key themes emerged: Negative encounters dominated. Isbell, PhD , of the University of Massachusetts Amherst, and colleagues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

Bauer, Senior Regulatory Drug Expert — Our readers probably know that we value and advocate for patient engagement as an essential component in the development of medical products (see our firm’s commitment here ).

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog

Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). FDA defines real-world data ( RWD ) as “data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources.” By Jeffrey N.

Medical 111
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice.

Clinic 52
article thumbnail

Second Circuit Agrees that Copay Assistance Programs May Violate the Anti-Kickback Statute

FDA Law Blog

Recognizing that this out-of-pocket cost still represents a significant financial barrier for many patients, Pfizer proposed a Direct Copay Assistance Program for Medicare Part D beneficiaries using tafamidis. Further, “there is little utility in comparing the language of the BIS to that of the AKS.”. The Lesson of this Case.

article thumbnail

510(k) Modernization 2023

FDA Law Blog

Baumhardt, Senior Medical Device Regulation Expert & Adrienne R. Lenz, Principal Medical Device Regulation Expert — On September 6, 2023, FDA announced its latest efforts to modernize the 510(k) process, outlining FDA’s latest improvements to strengthen the 510(k) Program and announcing release of three draft guidance documents.

Medical 64